This article is more than 5 years old. Information may no longer be current.

FDA grants CIBA additional claims

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATLANTA — CIBA Vision has been given clearance by the Food and Drug Administration to add two comfort claims to the packaging of Clear Care.

The claims, “improved ocular surface symptoms” and “80% of patients prefer Clear Care to their previous multipurpose solution,” resulted from a clinical study of Clear Care versus ReNu Multiplus, Opti-Free Express and Complete Comfort Plus.

According to a company press release, since May the Clear Care product has shown 140% growth.